announcements

announcements

The FDA just made GLP-1 access a national priority. We built the navigation guide.

Last month, the FDA's Commissioner's National Priority Voucher program identified drug affordability as one of five national priorities — creating a fast-track approval pathway for treatments that address cost and access barriers. For the GLP-1 community, that's significant. Ozempic, Wegovy, Mounjaro, and Zepbound have changed